Aquablation (robot surgeon)

2023: Product Announcement

On September 12, 2023, the American company Procept BioRobotics announced the development of the Aquablation robotic surgical system for the treatment of prostate tumors.

Aquaablation technology involves the use of hydroabrasive resection to precisely remove overgrown prostate tissue. The method avoids the use of high temperatures, which can harm the patient's body. Aquablation uses real-time ultrasound imaging. This makes it possible to draw up an individual treatment plan that takes into account the anatomy of each particular person. The very procedure of tissue excision using a water jet is carried out by a high-precision robot surgeon, which helps to maximize the effectiveness of the operation. In this case, doctors can indicate the areas of the prostate that should be removed.

Procept BioRobotics Aquablation

Aquaablation is indicated in patients with benign prostatic hyperplasia (BPH) - prostate adenoma. It is a benign tumor due to hyperplastic changes in the paraurethral glands. Pathology occurs in one in four to five men over the age of 40. It is noted that the use of aquaablation ensures the possibility of effective treatment of the disease while maintaining a high quality of life of patients. The U.S. Food and Drug Administration (FDA) has granted permission to Procept BioRobotics to conduct clinical studies on the safety and effectiveness of the Aquablation system.

Although the main task of our technology is to treat BPH, we see the potential of a robotic system in the therapy of other urological diseases, "said Reza Zadno, CEO of Procept BioRobotics[1]

Notes